1. Home
  2. ABCL vs RVNC Comparison

ABCL vs RVNC Comparison

Compare ABCL & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • RVNC
  • Stock Information
  • Founded
  • ABCL 2012
  • RVNC 1999
  • Country
  • ABCL Canada
  • RVNC United States
  • Employees
  • ABCL N/A
  • RVNC N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • RVNC Biotechnology: Pharmaceutical Preparations
  • Sector
  • ABCL Health Care
  • RVNC Health Care
  • Exchange
  • ABCL Nasdaq
  • RVNC Nasdaq
  • Market Cap
  • ABCL 719.0M
  • RVNC 599.6M
  • IPO Year
  • ABCL 2020
  • RVNC 2014
  • Fundamental
  • Price
  • ABCL $2.65
  • RVNC $4.17
  • Analyst Decision
  • ABCL Buy
  • RVNC Buy
  • Analyst Count
  • ABCL 3
  • RVNC 10
  • Target Price
  • ABCL $8.50
  • RVNC $10.23
  • AVG Volume (30 Days)
  • ABCL 2.6M
  • RVNC 2.8M
  • Earning Date
  • ABCL 11-04-2024
  • RVNC 11-07-2024
  • Dividend Yield
  • ABCL N/A
  • RVNC N/A
  • EPS Growth
  • ABCL N/A
  • RVNC N/A
  • EPS
  • ABCL N/A
  • RVNC N/A
  • Revenue
  • ABCL $32,962,000.00
  • RVNC $256,945,000.00
  • Revenue This Year
  • ABCL N/A
  • RVNC $20.36
  • Revenue Next Year
  • ABCL $38.78
  • RVNC $31.66
  • P/E Ratio
  • ABCL N/A
  • RVNC N/A
  • Revenue Growth
  • ABCL N/A
  • RVNC 25.82
  • 52 Week Low
  • ABCL $2.34
  • RVNC $2.30
  • 52 Week High
  • ABCL $6.06
  • RVNC $9.75
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 45.91
  • RVNC 36.84
  • Support Level
  • ABCL $2.62
  • RVNC $3.36
  • Resistance Level
  • ABCL $3.18
  • RVNC $4.37
  • Average True Range (ATR)
  • ABCL 0.18
  • RVNC 0.31
  • MACD
  • ABCL -0.01
  • RVNC -0.15
  • Stochastic Oscillator
  • ABCL 22.06
  • RVNC 31.03

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About RVNC Revance Therapeutics Inc.

Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.

Share on Social Networks: